This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,566,757,670 units of the medication XELJANZ XR 11 MG TABLET 30S. The $6,926.07 Firm Fixed Price delivery order has a completion date of December 19, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC enables the DLA to efficiently procure a wide range of pharmaceutical products and medical supplies, including specialty medications, generic drugs, and vaccines, to support military healthcare programs globally. No set-aside designation was applied to this specific contract award.
Generated 3/19/25, 9:54 AM